ArticleJournal of vascular research2026
Deletion of Murine Endothelial <italic>Bag3</italic> Alters the Cellular Proteome among Organs of Origin.
Article in Journal of vascular research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
10 authors.
Funding
Abstract
introductionBcl-2 associated athanogene 3 (BAG3) is a multifunctional protein with pleiotropic effects in multiple cell types. Despite our knowledge of its role in cardiovascular disease, its specific role in endothelial cells (ECs) is unknown. The purpose of this study was to identify differences in the EC proteome of multiple tissues before and after cell-specific deletion of Bag3. We hypothesized that BAG3 loss would uniquely alter the baseline proteome landscape of ECs in each tissue.
methodsCdh5(PAC)-CreERT2;Bag3f/f mice received tamoxifen (KO; n = 18) or vehicle (WT; n = 18) and tissues (brain, heart, lung, and peripheral skeletal muscle-SkM) were collected for fluorescence-activated cell sorting of ECs from equal numbers of male and female mice at >22 weeks of age, followed by LC-MS/MS label-free proteomics.
resultsInitial comparisons of the WT proteomes between tissues revealed differential abundance of EC proteins (p < 0.05), including 367 brain vs heart; 338 brain vs. lung; 570 brain vs. SkM; 400 heart vs. lung; 104 heart vs. SkM; and 489 lung vs. SkM. Additionally, the EC mitochondrial proteome was unique to each tissue of origin, with significantly (p < 0.05) higher proportions dedicated to complexes I, III, IV, and V, in the heart compared to the other tissues. KO demonstrated the largest effect on SkM ECs, increasing 31 proteins (Mybpc2 Log2FC = 4.81; PFKM Log2FC = 3.02) and decreasing 65 (CDC42 Log2FC = -2.44; Prpf8 Log2FC = -2.24).
conclusionOverall, these results demonstrate that the EC proteome of different tissues is unique and that the loss of BAG3 in these cells differentially alters a small proportion of the EC-specific proteome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.